Literature DB >> 9399468

Outcome of 350 implanted chest ports placed by interventional radiologists.

P C Shetty1, M K Mody, D J Kastan, R P Sharma, M W Burke, C Venugopal, T H Burke.   

Abstract

PURPOSE: To determine the outcome of implanted chest ports placed by interventional radiologists.
MATERIALS AND METHODS: Between June 1993 and July 1996, a single institution placed 350 implanted chest ports in 346 patients by means of the subclavian vein approach. The medical records of these patients were reviewed to determine the outcome of the ports. Ports were implanted for chemotherapy (n = 341), blood transfusion (n = 7), or antibiotics (n = 2).
RESULTS: Immediate complications were seven (2%) pneumothoraces and one (0.3%) hematoma. Four (1.1%) of the pneumothoraces necessitated hospital admission and treatment with a chest tube. The remaining three were managed on an outpatient basis. One was successfully treated in the interventional suite by catheter suction. Two pneumothoraces were observed and resolved spontaneously. Mean time of patient follow-up was 260 days (range, 22-929 days). Total time of follow-up was 91,000 catheter days. Delayed complications were 10 cases of thrombosis (2.9% or 0.11 per 1,000 catheter days) of the subclavian vein, four infections (1.1% or 0.04 per 1,000 catheter days), four catheter coiling or tip malpositions (1.1% or 0.04 per 1,000 catheter days), three catheter occlusions (0.9% or 0.03 per 1,000 catheter days), and one catheter leak (0.3% or 0.01 per 1,000 catheter days). Six (1.7%) ports had to be removed as a result of a delayed complication.
CONCLUSION: Chest port implantation by interventional radiologists within the radiology department is a successful and safe procedure with complication rates equivalent to, or lower than, those reported in surgical placement series.

Entities:  

Mesh:

Year:  1997        PMID: 9399468     DOI: 10.1016/s1051-0443(97)70699-7

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  18 in total

1.  Efficacy and safety of a single 2 mg dose or 4 mg double dose of alteplase for 50 occluded chest ports using a unique instillation technique.

Authors:  Rajinder P Sharma; Chung Ja Ree; Alexander Ree
Journal:  Int J Angiol       Date:  2008

Review 2.  Extravasation of chemotherapy.

Authors:  Seppo W Langer
Journal:  Curr Oncol Rep       Date:  2010-07       Impact factor: 5.075

3.  Outcome analysis in 3,160 implantations of radiologically guided placements of totally implantable central venous port systems.

Authors:  Ulf K M Teichgräber; Stephan Kausche; Sebastian N Nagel; Bernhard Gebauer
Journal:  Eur Radiol       Date:  2011-01-05       Impact factor: 5.315

4.  Totally Implantable Central Venous Port Catheters: Radiation Exposure as a Function of Puncture Site and Operator Experience.

Authors:  Martin Jonczyk; Bernhard Gebauer; Roman Rotzinger; Dirk Schnapauff; Bernd Hamm; Federico Collettini
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

5.  Central venous port systems as an integral part of chemotherapy.

Authors:  Ulf K Teichgräber; Robert Pfitzmann; Herbert A F Hofmann
Journal:  Dtsch Arztebl Int       Date:  2011-03-04       Impact factor: 5.594

Review 6.  Systematic review: malfunction of totally implantable venous access devices in cancer patients.

Authors:  Godelieve Alice Goossens; Marguerite Stas; Martine Jérôme; Philip Moons
Journal:  Support Care Cancer       Date:  2011-05-10       Impact factor: 3.603

Review 7.  Central venous access: techniques and indications in oncology.

Authors:  Pierre-Yves Marcy
Journal:  Eur Radiol       Date:  2008-05-06       Impact factor: 5.315

8.  Long-term outcomes of peripheral arm ports implanted in patients with colorectal cancer.

Authors:  Junichiro Kawamura; Satoshi Nagayama; Akinari Nomura; Atsushi Itami; Hiroshi Okabe; Seiji Sato; Go Watanabe; Yoshiharu Sakai
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

9.  Safety of a totally implantable central venous port system with percutaneous subclavian vein access.

Authors:  Dong-Yoon Keum; Jae-Bum Kim; Min-Cheol Chae
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-06-05

10.  1000 Port-A-Cath ® placements by subclavian vein approach: single surgeon experience.

Authors:  S Mudan; A Giakoustidis; D Morrison; S Iosifidou; R Raobaikady; K Neofytou; J Stebbing
Journal:  World J Surg       Date:  2015-02       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.